V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270019208 | 270010155 | 1.7 | 67.7 | Palliative (P) | 2016-09-09 | 2016-09-17 | ETOPOSIDE | N | N | 270018394 | VINCRISTINE |
| 270019209 | 270019709 | null | null | Palliative (P) | null | 2017-12-01 | Methotrexate intrathecal | null | null | 270018427 | HYDROXYCARBAMIDE |
| 270019210 | 270010159 | null | null | Palliative (P) | 2016-06-28 | 2016-07-03 | CYCLOPHOSPHAMIDE + ETOPOSIDE + LOMUSTINE | 2 | null | 270018448 | GEMCITABINE + OXALIPLATIN |
| 270019211 | 270014747 | 1.61 | -1 | Disease modification (D) | 2017-04-21 | 2017-04-21 | Etoposide IV | N | null | 270018453 | CHLORAMBUCIL + ETOPOSIDE + LOMUSTINE |
| 270019212 | 270010164 | 1.62 | 80.1 | Curative (C) | 2015-06-20 | 2015-06-26 | IBRUTINIB | null | N | 270018470 | CARBO + FLUOROURACIL |
| 270019213 | 270010167 | null | 53.4 | Disease modification (D) | 2014-12-18 | 2014-12-18 | IBRUTINIB | 2 | N | 270018473 | ECHELON 1 TRIAL |
| 270019215 | 270014751 | 1.8 | 58 | Curative (C) | 2015-08-05 | 2015-08-05 | METHOTREXATE | 2 | N | 270018521 | DACARBAZINE + DOXORUBICIN + VINBLASTINE |
| 270019216 | 270014753 | 1.74 | 0 | Curative (C) | 2016-06-23 | 2016-06-24 | CTD | N | N | 270018542 | CYCLOPHOSPHAMIDE |
| 270019217 | 270010185 | null | 98 | Palliative (P) | 2017-10-30 | 2018-02-09 | Hydroxycarbamide | N | N | 270018706 | DACARBAZINE |
| 270019218 | 270010192 | 1.65 | 86 | Not known (9) | 2018-05-02 | 2018-05-28 | Dacarbazine | Y | N | 270018776 | ETOPOSIDE |
| 270019219 | 270010201 | 1.7 | 75.9 | Curative (C) | 2017-04-25 | 2017-04-25 | CYCLOPHOSPHAMIDE | N | null | 270018827 | CVP |
| 270019220 | 270010203 | 1.79 | 54.6 | Palliative (P) | 2013-07-30 | 2013-08-11 | Cetuximab + CISPLATIN | 2 | N | 270018829 | IMATINIB |
| 270019221 | 270010208 | 1.78 | 80 | Curative (C) | null | 2017-10-08 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | null | N | 270018834 | NILOTINIB |
| 270019222 | 270010209 | 1.54 | 50.6 | Palliative (P) | 2015-10-12 | 2015-12-20 | BREVITY TRIAL | 01 | N | 270018840 | IBRUTINIB |
| 270019223 | 270010218 | 1.54 | 45 | Curative (C) | null | 2017-06-11 | Methotrexate intrathecal | 2 | N | 270018889 | MATRIX TRIAL |
| 270019224 | 270014776 | 1.59 | 50.8 | Curative (C) | 2019-06-08 | 2019-06-11 | Melphalan IV High dose | N | N | 270018894 | METHOTREXATE |
| 270019225 | 270010234 | 1.7 | 83.6 | Curative (C) | 2012-09-29 | 2017-01-20 | CARBOPLATIN + GEMCITABINE | 2 | N | 270019172 | CVP |
| 270019226 | 270010239 | 1.73 | 80.3 | Adjuvant (A) | 2017-09-19 | 2017-09-28 | Temozolomide 150mg/m2 | N | N | 270019251 | CYCLOPHOSPHAMIDE |
| 270019227 | 270014785 | 1.8 | 82 | Palliative (P) | 2016-04-24 | 2016-06-15 | Bevacizumab + CAPECITABINE + OXALIPLATIN | N | N | 270019316 | CARBOPLATIN + CETUXIMAB + FU |
| 270019228 | 270010250 | 1.73 | 71.7 | Curative (C) | 2014-08-07 | 2014-08-11 | IVE-R | N | N | 270019375 | ESHAP R |
| 270019229 | 270010262 | 1.84 | 62 | Palliative (P) | 2018-08-29 | 2018-09-02 | Triple / Double Intrathecal Therapy | 2 | N | 270019450 | PMITCEBO |
| 270019230 | 270010269 | 1.84 | 43.8 | Curative (C) | 2015-02-01 | 2015-02-09 | CVP | N | N | 270019599 | FEC |
| 270019231 | 270010272 | 1.83 | 87 | Curative (C) | 2014-11-08 | 2014-11-12 | CYCLOPHOSPHAMIDE | N | Y | 270019601 | DOCETAXEL |
| 270019232 | 270014801 | 1.78 | 69.3 | Disease modification (D) | 2017-08-28 | 2017-08-30 | Cytarabine High Dose | N | N | 270019721 | RATHL TRIAL |
| 270019233 | 270017163 | null | null | Curative (C) | 2015-05-26 | 2015-05-31 | CHLVPP PABLOE | N | N | 270019757 | BENDAMUSTINE + RITUXIMAB |
| 270019234 | 270010295 | 0 | 102.7 | Curative (C) | 2015-12-19 | 2016-06-21 | FCR | N | N | 270019813 | METHOTREXATE HIGH DOSE |
| 270019235 | 270010300 | 1.59 | 54.4 | Palliative (P) | 2018-07-27 | 2018-08-03 | Y-90 | null | N | 270019883 | LACE |
| 270019236 | 270010307 | 1.69 | 101.2 | Curative (C) | 2018-01-25 | 2018-02-13 | Dasatinib | N | N | 270019915 | CHOP |
| 270019237 | 270010310 | 1.71 | null | Palliative (P) | 2014-08-18 | 2014-08-18 | BLEOMYCIN | N | null | 270019944 | DOXORUBICIN |
| 270019238 | 270010315 | 1.86 | null | Curative (C) | null | 2013-11-05 | BLEOMYCIN | null | null | 270019972 | DACARBAZINE + DOXORUBICIN + VINBLASTINE |
| 270019239 | 270010321 | 1.73 | 62.5 | Palliative (P) | 2018-01-31 | 2018-04-28 | ICE | N | N | 270019995 | METHOTREXATE INTRATHECAL |
| 270019240 | 270010326 | 1.78 | null | Palliative (P) | 2014-02-26 | 2014-03-19 | METHOTREXATE | N | N | 270019996 | DHAP - R |
| 270019241 | 270010331 | 1.69 | 73.5 | Curative (C) | 2016-08-17 | 2016-08-29 | IGEV R | N | N | 270020035 | RATHL TRIAL |
| 270019242 | 270014825 | 1.73 | 91.8 | Adjuvant (A) | 2019-05-06 | 2019-05-07 | DACARBAZINE + DOXORUBICIN + VINBLASTINE | 2 | N | 270020060 | MELPHALAN |
| 270019243 | 270014829 | 1.74 | 70 | Curative (C) | 2015-08-21 | 2015-08-23 | CHLVPP PABLOE | 02 | N | 270020119 | BENDAMUSTINE + RITUXIMAB |
| 270019244 | 270014832 | null | 142 | Palliative (P) | 2017-05-20 | 2018-03-18 | DACARBAZINE + DOXORUBICIN + VINBLASTINE | N | N | 270020201 | LACE |
| 270019245 | 270010356 | 1.83 | 70 | Palliative (P) | 2015-11-20 | 2015-12-20 | CARMUSTINE + CYTARABINE + ETOPOSIDE | N | N | 270020297 | BREVITY TRIAL |
| 270019246 | 270010365 | 1.82 | 94 | null | 2015-06-12 | 2015-06-14 | Nilotinib | 2 | N | 270020411 | LENALIDOMIDE |
| 270019247 | 270010370 | null | null | Palliative (P) | 2016-12-23 | 2018-05-09 | Methotrexate intrathecal | 02 | N | 270020545 | ICE |
| 270019248 | 270014845 | 1.6 | 106.7 | null | 2018-01-19 | 2018-03-24 | Abiraterone | N | N | 270020549 | FLUDARABINE + MELPHALAN |
| 270019249 | 270010377 | null | 142 | Curative (C) | 2014-01-11 | 2014-01-12 | CYCLOPHOSPHAMIDE | N | N | 270020635 | ICE |
| 270019250 | 270010382 | 1.6 | 55 | Neo-adjuvant (N) | 2016-03-08 | 2016-03-11 | BENDAMUSTINE + CYTARABINE + ETOPOSIDE + MELPHALAN | 02 | N | 270020661 | DACARBAZINE + DOXORUBICIN + VINBLASTINE |
| 270019251 | 270014851 | 1.78 | 44.6 | Adjuvant (A) | 2018-10-17 | 2018-10-18 | NHL 2003 Gp B COPADM 1 & 2 | 2 | N | 270020719 | CHOP |
| 270019252 | 270014852 | null | null | Curative (C) | 2019-01-24 | 2019-02-01 | Hydroxycarbamide | null | null | 270020741 | GEMCARBO |
| 270019253 | 270010392 | 1.63 | 73.6 | Neo-adjuvant (N) | 2014-04-12 | 2014-04-19 | AFATINIB | 02 | N | 270020762 | BORTEZOMIB + PANOBINOSTAT |
| 270019254 | 270010407 | null | 105 | Palliative (P) | 2017-06-18 | 2018-05-25 | RATHL TRIAL | 02 | N | 270021045 | RCEOP |
| 270019255 | 270010430 | 1.79 | 74 | Not known (9) | 2015-04-22 | 2015-07-08 | CVP R | N | N | 270021486 | DTPACE |
| 270019256 | 270010433 | 1.9 | 75 | Palliative (P) | 2018-10-06 | 2019-12-17 | GEMCITABINE + VINORELBINE | N | null | 270021516 | ETOPOSIDE |
| 270019257 | 270010444 | 1.64 | 81 | Curative (C) | 2017-03-27 | 2017-03-31 | CHOP R + BORTEZOMIB | N | N | 270021829 | DOCETAXEL |
| 270019258 | 270010447 | 0 | 71.1 | Curative (C) | 2016-10-04 | 2016-10-17 | Cyclophosphamide+Fludara+TBI Allo | N | N | 270021842 | CHLVPP/PABLOE |